Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Mirosława Puskulluoglu"'
Autor:
Mirosława Püsküllüoğlu, Małgorzata Pieniążek, Agnieszka Rudzińska, Agnieszka Pietruszka, Renata Pacholczak-Madej, Aleksandra Grela-Wojewoda, Marek Ziobro
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 419-435 (2024)
Abstract Introduction Hepatic visceral crisis (VC), characterized by a rapid total bilirubin increase with disease progression, poses a life-threatening risk in advanced breast cancer (ABC). International consensus guidelines define VC and touch on i
Externí odkaz:
https://doaj.org/article/2e5ca5c1cf26422ea52090d6e247ad13
Autor:
Mirosława Püsküllüoğlu, Aleksandra Konieczna, Katarzyna Świderska, Joanna Streb, Małgorzata Pieniążek, Aleksandra Grela-Wojewoda, Renata Pacholczak-Madej, Anna Mucha-Małecka, Jerzy W. Mituś, Joanna Szpor, Michał Kunkiel, Agnieszka Rudzińska, Michał Jarząb, Marek Ziobro
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: Metaplastic breast carcinoma (BC-Mp) is an uncommon subtype that poses unique challenges. The limited information on patient prognosis and therapeutic strategies motivated our research initiative. We aimed to assess disease-fr
Externí odkaz:
https://doaj.org/article/61f16568976e4d8daaf33a8feee12a11
Autor:
Mirosława Püsküllüoğlu, Aleksandra Grela-Wojewoda, Aleksandra Ambicka, Renata Pacholczak-Madej, Agnieszka Pietruszka, Anna Mucha-Małecka, Agnieszka Rudzińska, Marek Ziobro, Janusz Ryś, Jerzy W. Mituś
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundPrimary neuroendocrine neoplasms of the breast (Br-NENs) are rare. The classification has been updated in recent years making interpretation of the data published challenging. It is unclear whether neuroendocrine differentiation is associat
Externí odkaz:
https://doaj.org/article/fb83a84e9e484249b6a9fd41ea5dfa99
Autor:
Miroslawa Püsküllüoğlu, Marek Ziobro, Joanna Lompart, Agnieszka Rudzińska, Tomasz Zemełka, Justyna Jaworska, Sebastian Ochenduszko, Aleksandra Grela-Wojewoda
Publikováno v:
Cancers, Vol 16, Iss 16, p 2894 (2024)
The standard therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer includes the use of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) with endocrine therapy. The optimal post-CDK4/6i treatme
Externí odkaz:
https://doaj.org/article/093a8bfb606e4d27a390722a27dc42a7
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Breast cancer (BC) is a heterogenous disease, with prognosis and treatment options depending on Estrogen, Progesterone receptor, and Human Epidermal Growth Factor Receptor-2 (HER-2) status. HER-2 negative, endocrine-independent BC presents a signific
Externí odkaz:
https://doaj.org/article/cb45008b5a3541c5bfb7ebe393b8a7d7
Autor:
Mirosława Püsküllüoğlu, Katarzyna Świderska, Aleksandra Konieczna, Wojciech Rudnicki, Renata Pacholczak-Madej, Michał Kunkiel, Aleksandra Grela-Wojewoda, Anna Mucha-Małecka, Jerzy W. Mituś, Ewa Stobiecka, Janusz Ryś, Michał Jarząb, Marek Ziobro
Publikováno v:
Cancers, Vol 16, Iss 1, p 188 (2023)
Metaplastic breast cancer (BC-Mp) presents diagnostic and therapeutic complexities, with scant literature available. Correct assessment of tumor size by ultrasound (US) and full-field digital mammography (FFDM) is crucial for treatment planning. Meth
Externí odkaz:
https://doaj.org/article/19658a9f27b14190aa5b249e71ae4e47
Autor:
Aleksandra Grela-Wojewoda, Mirosława Püsküllüoğlu, Beata Sas-Korczyńska, Tomasz Zemełka, Renata Pacholczak-Madej, Wojciech M. Wysocki, Tomasz Wojewoda, Agnieszka Adamczyk, Joanna Lompart, Michał Korman, Anna Mucha-Małecka, Marek Ziobro, Ewa Konduracka
Publikováno v:
Cancers, Vol 14, Iss 14, p 3353 (2022)
Trastuzumab-induced cardiotoxicity (TIC) can lead to early treatment discontinuation. The aim of this study was to evaluate: N-terminal brain natriuretic peptide (NT-proBNP), creatine kinase-MB (CK-MB), myoglobin, and selected biochemical and clinica
Externí odkaz:
https://doaj.org/article/01196921a97f499189c45cdf92509e86
Autor:
Renata Pacholczak-Madej, Aleksandra Grela-Wojewoda, Mirosława Puskulluoglu, Joanna Lompart, Manuela Las-Jankowska, Katarzyna Krawczak, Ewa Wrona, Lech Zaręba, Justyna Żubrowska, Jerzy Walocha, Stanisława Bazan-Socha, Marek Ziobro
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2528 (2022)
Nivolumab and ipilimumab combination became the first-line standard in advanced melanoma. We assessed its efficacy in a real-life study in Poland. In a one-year follow-up, we evaluated the medical records of 50 melanoma patients treated with that mod
Externí odkaz:
https://doaj.org/article/b5cf9ecd12f24219ba5cbad3ce0cc533
Publikováno v:
Contemporary Oncology, Vol 20, Iss 2, Pp 119-123 (2016)
Acupuncture is a complementary and alternative medical treatment (CAM) which is increasingly used in the care of cancer patients. Traditionally derived from Chinese medicine, nowadays it is becoming a part of evidence-based oncology. The use of acupu
Externí odkaz:
https://doaj.org/article/9ef2c06a3ace4eb9928c4c29b31f4d92
Autor:
Sebastian Ochenduszko, Mirosława Puskulluoglu, Kamil Konopka, Kamil Fijorek, Agnieszka Julia Slowik, Michał Pędziwiatr, Andrzej Budzyński
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Background: Randomized clinical trials showed improved overall survival (OS) of advanced gastroesophageal adenocarcinoma (GEA) patients treated with second-line taxane or irinotecan. However, most data on irinotecan efficacy in this setting come from
Externí odkaz:
https://doaj.org/article/55fd8682d4a14c63a3e0e25f29b6dc4b